New Study Shows Abortion Bans Are Making Healthcare More Expensive for Women and Families

The landscape of American healthcare underwent a seismic shift following the Supreme Court’s 2022 decision in Dobbs v. Jackson Women’s Health Organization, which overturned the constitutional right to abortion. While the legal and political ramifications of this ruling have dominated national discourse, a new working paper released by University of Michigan researchers Dr. Joelle Abramowitz and Olga Aristova suggests that the economic ripple effects of these bans are now manifesting in the household budgets of millions of American women. By analyzing data spanning from 2018 to 2024, the study provides evidence that state-level abortion restrictions are directly correlated with increased out-of-pocket health insurance premiums, creating a compounding financial burden for families already navigating a strained post-Dobbs medical environment.

The Economic Mechanism of Healthcare Inflation

The premise of the study, titled Effects of Post-Dobbs Abortion Bans on Medical Out-of-Pocket Expenditures, rests on the intersection of reproductive health policy and actuarial science. As states implemented strict bans or total prohibitions on abortion, the medical landscape in those jurisdictions shifted significantly. The researchers observed that the restriction of reproductive services led to a measurable increase in pregnancy-related complications, high-risk birth scenarios, and maternal and infant mortality rates.

From an insurance perspective, this increase in medical acuity represents a heightened risk profile for the insured population. When the frequency and severity of medical events—such as emergency sepsis care for complications or intensive neonatal care—rise, the cost of coverage increases. Insurance providers, operating under the mandate of fiscal solvency, frequently pass these elevated systemic costs on to policyholders. Consequently, the research suggests that women of reproductive age (18-44) in states with restrictive abortion laws are effectively subsidizing the broader systemic strain through higher individual premium payments.

Chronology of Policy and Financial Impact

To understand the significance of these findings, one must look at the timeline of the shifting legal and economic terrain. Prior to the June 2022 Dobbs decision, researchers noted a relative parity in out-of-pocket healthcare expenditures between states that would eventually move to ban abortion and those that maintained reproductive healthcare protections. The Current Population Survey Annual Social and Economic Supplement, which served as the primary data set for this study, tracked 60,000 women during the pre- and post-Dobbs periods.

Following the Supreme Court ruling, the divergence in financial data became statistically significant. In states where abortion access was curtailed, the rate of reported out-of-pocket spending began to climb at a steeper trajectory than in states where access remained protected. By 2024, the cumulative effect of these premiums had created a measurable gap, indicating that the legislative act of banning abortion created an immediate and sustained inflationary pressure on the private insurance market within those borders.

Disproportionate Impacts on Marginalized Communities

One of the most concerning findings in the Abramowitz-Aristova study is the uneven distribution of these costs. While the economic impact of rising premiums is felt across the board, the study highlights that Black and Hispanic women are experiencing a more pronounced financial burden. This finding aligns with long-standing disparities in the American healthcare system, where minority populations have historically faced higher barriers to care and lower insurance coverage stability.

Economic analysts suggest that these groups are often more sensitive to fluctuations in premium costs, as they may occupy a higher percentage of lower-to-middle-income brackets where healthcare spending consumes a larger share of the total household income. When premiums rise, these families are forced to choose between essential coverage and other basic necessities—a phenomenon often described as the "medical poverty trap." The fact that the economic consequences of abortion bans are not felt equally suggests that these policies are exacerbating existing socioeconomic inequalities rather than merely serving as a neutral regulatory change.

The Broader Healthcare Ecosystem

The implications of this study extend well beyond the individual household. For the broader healthcare system, the rise in premiums represents a signal of instability. When insurers increase premiums in response to rising maternal mortality and pregnancy complications, the entire market begins to reflect the "spillover effects" of the policy shift.

"The data show that women in states with abortion bans are more likely to pay out of pocket for health insurance premiums," Dr. Joelle Abramowitz noted in her summary of the findings. "Insurers may also be passing costs to beneficiaries in response to increased risk imposed by the spillover effects from abortion bans."

This suggests a feedback loop: as abortion access is limited, pregnancy becomes a higher-risk medical event from the perspective of insurers. This risk is then priced into the premiums for all women of reproductive age within that state, regardless of their individual medical history or pregnancy status. This systemic pricing mechanism means that even those not seeking reproductive services are caught in the wake of the policy changes, as their insurance plans adjust to the new reality of higher mortality and complication rates.

Official Responses and Industry Context

The release of this working paper has prompted responses from advocates and health policy experts who argue that the findings provide the "missing link" in the argument against abortion bans. Rachana Desai Martin, Chief Program Officer for the Center for Reproductive Rights, characterized the report as definitive evidence that abortion bans function as a "kitchen-table issue."

"We know that bans limit access to care," Martin stated. "Now we have the data to prove that they make health insurance more expensive, too."

From the perspective of the insurance industry, the adjustments to premiums are standard actuarial responses to changing population health data. However, health economists point out that the legislative environment has essentially turned a medical decision into a public health variable that carries a direct price tag. As maternal health outcomes continue to fluctuate in states with strict bans, industry observers expect these premium trends to persist, potentially leading to a wider "coverage gap" where insurance becomes increasingly unaffordable for the demographics most likely to be affected by these policies.

Future Implications and Policy Considerations

The Abramowitz-Aristova study serves as a critical entry point for future research into the intersection of reproductive law and economic stability. As the 2026 election cycle approaches, the financial burden of these policies may play an increasing role in state-level legislative debates. Lawmakers in states with abortion bans may face pressure to address the rising cost of living for families, a challenge that is now inextricably linked to the state of reproductive healthcare access.

Furthermore, the study raises questions regarding the sustainability of current insurance models in states with highly restrictive reproductive health environments. If premiums continue to rise, there is a risk of a "death spiral" in certain markets, where healthy individuals drop coverage due to high costs, leaving behind a sicker and more expensive pool of beneficiaries, which in turn necessitates further premium hikes.

The findings also provide a roadmap for policymakers looking to mitigate the economic fallout of post-Dobbs legislation. Potential interventions could include state-subsidized insurance pools for low-income women, increased investment in maternal health infrastructure to reduce the complications driving the premiums, or legislative oversight into how insurance companies calculate and pass on these specific risks.

Ultimately, the research by Dr. Abramowitz and Aristova shifts the conversation from a purely ethical or political debate to one of quantifiable economic impact. By demonstrating that abortion bans carry a specific, measurable cost for women and their families, the study adds a new dimension to the national dialogue, forcing a confrontation with the reality that the cost of limiting reproductive access is being paid, quite literally, at the checkout counter of the American healthcare system. As more data from the post-Dobbs era becomes available, the long-term economic trajectory for women’s health insurance will remain a focal point for researchers, regulators, and the families who are currently bearing the weight of these rising costs.